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A growing body of evidence suggests the consumption of high-fat diet (HFD) during
pregnancy to model maternal obesity and the associated increase in oxidative stress
(OS), might act as powerful prenatal stressors, leading to adult stress-related metabolic
or behavioral disorders. We hypothesized that administration of antioxidants throughout
gestation might counteract the negative effects of prenatal exposure to metabolic
challenges (maternal HFD feeding during pregnancy) on the developing fetus. In this
study, female C57BL/6J mice were fed HFD for 13 weeks (from 5-weeks of age
until delivery) and were exposed to the N-acetyl-cysteine (NAC) antioxidant from
10-weeks of age until right before delivery. Body weight of the offspring was assessed
following birth, up to weaning and at adulthood. The metabolic, neuroendocrine and
emotional profile of the adult offspring was tested at 3-months of age. Prenatal HFD
increased mother’s body weight and offspring’s weight at the time of weaning, when
administered in conjunction with NAC. In females, NAC administration reduced high
levels of leptin resulting from prenatal HFD. Prenatal NAC administration also resulted
in greater glucose tolerance and insulin sensitivity while increasing adiponectin levels,
as well as increasing exploratory behavior, an effect accompanied by reduced plasma
corticosterone levels in response to restraint stress. Analysis of glutathione levels in
the hypothalamus and in brown adipose tissue indicates that, while HFD administration
to pregnant dams led to reduced levels of glutathione in the offspring, as in the male
hypothalamus, NAC was able to revert this effect and to increase glutathione levels both
in the periphery (Brown Adipose Tissue, both males and females) and in the central
nervous system (males). Overall, results from this study indicate that the body redox
milieu should be tightly regulated during fetal life and that buffering OS during pregnancy
can have important long-term consequences on metabolic and behavioral endpoints.
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INTRODUCTION
In Western society the consumption of high fat diet (HFD) as
well as a sedentary lifestyle has been associated with metabolic
derangements and impaired brain plasticity (Schrauwen and
Westerterp, 2000; Unger and Orci, 2001; McGarry, 2002;
Molteni et al., 2002, 2004). While it is generally accepted
that HFD-induced obesity per se is associated with adverse
health outcomes, some studies have also shown that maternal
obesity is specifically associated with a variety of pregnancy
complications, fetal and neonatal death, maternal hypertension
and gestational diabetes (Lu et al., 2001; Bhattacharya and
Sood, 2007; Thompson, 2008). Moreover, it is possible to
hypothesize that maternal obesity might increase in the offspring,
vulnerability for cardiovascular or metabolic pathological
conditions, in addition to the often comorbid mood-disorders.
Indeed, evidence suggests that epigenetic events initiated by HFD
exposure during the prenatal period can result in persistent
adaptations in physiological and metabolic regulations of the
developing organism, predisposing the offspring towards disease
(Barker, 1995; Lucas, 1998). Furthermore, HFD may negatively
impact on metabolic regulation resulting in excess energy intake
and increased adiposity (Woods et al., 2004; Zhang et al.,
2009) also associated to low-grade inflammation and increased
production of inflammatory cytokines (Chandalia and Abate,
2007).
Several studies have shown that administration of high fat or
high calorie diets to rodents increases the generation of reactive
oxygen species (ROS; Zhang et al., 2005) and protein oxidation
(Souza et al., 2007), thus resulting in increased oxidative damage
in the brain (Cecarini et al., 2007; Bruce-Keller et al., 2009;
Zhang et al., 2009) and, more in general, in oxidative cell injury
(Gutteridge and Halliwell, 2000). This evidence is consistent with
the hypothesis that increased oxidative stress (OS) may mediate
the effects of HFD consumption both on brain health and mood
disorders and may as well exacerbate the HFD-related metabolic
impairment.
In a previous work performed in mice (Bellisario et al.,
2014), we found that the detrimental effect of prenatal exposure
to a maternal HFD was counteracted by the lack of the
p66Shc gene that results, among other several features, in
reduced OS and resistance to diet-induced obesity. More in
detail, p66Shc /  mice showed blunted changes in glycaemia
levels in response to glucose or insulin challenges and were
protected from the disrupting effect of prenatal HFD on
neuroendocrine activation in response to a psychophysical
stress (Bellisario et al., 2014). These findings suggested that
reduced OS might increase resistance to impaired physiological
adaptation driven by maternal HFD in the offspring during
adult life. In light of this evidence, this study was aimed at
developing a pharmacological model of reduced OS able to
cope with metabolic challenges occurring during early life by
means of prenatal administration of N-acetyl-cysteine (NAC).
This compound is the rate-limiting substrate in the biosynthesis
of glutathione, is a powerful antioxidant and a ROS scavenger;
its clinical efficacy and safety as a mucolytic drug have been
widely established in the last decades, both as a therapy for
respiratory diseases and as a remedy towards several acute
intoxications including the most common acetaminophen drug
overdose (Crystal and Bast, 1991; Samuni et al., 2013). NAC
is ‘‘a safe and well-tolerated supplementary drug without any
considerable side effects commonly used in clinical practice for
a variety of different disorders ranging from polycystic ovary
syndrome, preterm-birth, recurrent pregnancy loss, chronic
bronchitis, ulcerative colitis, liver cancer, muscle performance,
asthma, Alzheimer and Parkinson’’ (see Mokhtari et al., 2017 and
references therein for a complete review). Furthermore, there is
evidence showing that NAC administration during pregnancy
might counteract apoptosis and ROS-related genotoxicity by
increasing glutathione levels and decreasing mitochondrial
membrane depolarization within the cells (Amin et al.,
2008).
Our working hypothesis was that administration of the
antioxidant NAC during prenatal life might increase glutathione
levels, preventing the negative effects exerted by increased ROS
resulting from maternal HFD administration on metabolic and
behavioral endpoints in the offspring. In addition, a growing
body of evidence suggests a direct link between redox imbalance
and emotional disturbance, particularly anxiety (Hovatta et al.,
2005 and maternal obesity has been also independently related
to increased incidence of mood disorders in the offspring
(Bouayed et al., 2009; Contu and Hawkes, 2017; Edlow, 2017).
Thus, another hypothesis to be tested was that a metabolic
stressor, such as prenatal HFD, might lead to increased
anxiety in the offspring and that NAC would prevent this
effect.
To test such hypothesis female mice were fed HFD or
control diet (CD) for 13 weeks (from 5 weeks of age until right
before delivery) and were exposed to NAC for 8 weeks (from
10 weeks of age until right before delivery). The offspring was
subsequently phenotyped formetabolic and behavioral responses
at adulthood.
MATERIALS AND METHODS
Animals
Experimental subjects were male and female adult offspring
(3 months of age) of C57Bl/6J female mice fed HFD or CD—see
below.
All mice were housed two/cage in transparent Plexiglas cages
provided by Tecniplast, in an air-conditioned room (temperature
21± 1 C, relative humidity 60± 10%), under a reversed 12/12 h
light/dark cycle with lights off from 07:00 a.m. to 07:00 p.m.
Fresh tap-water and standard chow (standard diet—SD—energy
3.3 kcal/g, fat 17%, carbohydrate 60% and protein 23% provided
by Altromin-R, Rieper, Italy) were continuously available until
5 weeks of age.
Diet Administration
At 5 weeks of age, all females (n = 77) were fed ad libitum either
with HFD (energy 5.56 kcal/g, fat 58%, carbohydrate 25.5% and
protein 16.4%; n = 43) or CD (energy 4.07 kcal/g, fat 10.5%,
carbohydrate 73.1% and protein 16.4%; n = 34) for 13 weeks,
i.e., until right before delivery. Females were randomly assigned
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to HFD or CD groups and subjects were counterbalanced to
avoid biases due to body weight. High-fat (D12331) and control
(D12328) diets were provided by Research Diets Inc., New
Brunswick, NJ, USA.
NAC Antioxidant Administration
After 5 weeks on the diets, females underwent antioxidant
treatment with NAC (or tap water as control), for 5 weeks, until
the end of dietary treatment. In order to minimize stress due to
excessive handling procedure by the experimenter NAC (Sigma-
Aldrich) was daily administered in drinking water (Balansky
et al., 1996), to yield an average dose of 1 g/kg body weight.
Breeding Procedure
At 15 weeks of age, after 10 weeks on the diet and 5 weeks of NAC
administration, all females were bred (see Bellisario et al., 2014
for further details on the breeding procedure; Brockman et al.,
1998).
After mating, dams were kept with either HFD or CD and
NAC throughout gestation until 3 days before the expected
delivery date (i.e., gestational day 16—G16); by this time NAC
administration was also stopped and all dams were shifted
onto SD (see Bellisario et al., 2014). Body weight gain of
pregnant females was monitored once a week throughout the
5 weeks of combined exposure to HFD and NAC. Pups’
birth was considered as post-natal day 0 (PND 0). At PND
3 pups’ weight was registered, as well as at PND 30, when
all pups were also weaned onto SD. Starting at 9 weeks
of age, both male and female offspring were weighed and
tested to assess the metabolic and emotional profiles resulting
from prenatal exposure to a HFD diet and the role of
antioxidants on these regulations. A schematic design of the
experimental plan is reported in Figure 1. All experimental
procedures were conducted in conformity with the European
Directive 2010/63/EU and the Italian legislation on animal
experimentation, D.Lgs.vo 26/2014 and were approved by the
Istituto Superiore di Sanità Ethical Committee (Organismo
Preposto per il Benessere Animale—OPBA) and by the Italian
Ministry of Health.
EXPERIMENTAL PROCEDURES
Metabolic Regulation
Glucose Tolerance Test (GTT)
Intra-peritoneal Glucose Tolerance Test (GTT) was performed
after a 15 h overnight fasting that took place from 06:30 p.m.
to 09:30 a.m. Animals were intra-peritoneally (ip) loaded with
2 g/kg body weight D-glucose (10% D glucose solution; Sigma,
St. Louis, MO, USA; Satapathy et al., 2011). Blood was collected
from the tail vein at 0 (baseline), 30, 60, 120 and 180 min (Ranieri
et al., 2010) following ip injection and glycemia (blood glucose
concentration) was measured using a commercial glucometer
(StatStrip Xpress-i, nova biomedical, A. Menarini diagnostic;
Titta et al., 2010).
Insulin Sensitivity Test (IST)
The test was performed on animals starved for 5 h that took
place from 09:30 a.m. to 02:30 p.m. Glycemia wasmeasured using
a commercial glucometer (StatStrip Xpress-i, nova biomedical,
A. Menarini diagnostic) immediately before (0) and 15, 30, 60,
120 min after ip injection of a 0.4 U/kg body weight (Titta et al.,
2010) solution of human recombinant insulin (Humulin, Eli-
Lilly, 100 U/mL; Ranieri et al., 2010).
Metabolic Hormones Assessment
Plasma levels of leptin and adiponectin were assessed under
starving condition. Blood samples were collected from the tail
vein in potassium EDTA coated tubes (1.6 mgEDTA/mlblood;
Sarstedt, Germany) at 09:30 a.m., 15 h after removal of
food (see ‘‘Glucose Tolerance Test (GTT)’’ section above).
After centrifugation, plasma samples were used for the
determination of leptin (MouseLeptin Elisa kit, CrystalChemInc.,
DownersGrove, IL, USA) and adiponectin levels (Elisa kit,
B-BridgeInternational, Inc., Santa Clara, CA, USA).
All subjects underwent the GTT as first metabolic test
and after 3 days, in which mice were left undisturbed, all of
them were tested for the Insulin Sensitivity Test (IST). This
time interval was necessary to recover from the fasting and
the handling procedures. Five days following the end of the
metabolic measurement subjects underwent behavioral tests.
FIGURE 1 | Graphical representation of the experimental timeline. HFD, high-fat diet; CD, control diet; SD, standard diet; NAC, N-acetyl-cysteine; PND, postnatal
day; G, gestational day; GTT, Glucose tolerance test; IST, insulin sensitivity test; OF, open field; EPM, elevated plus maze.
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Plasma Corticosterone in Response to
Restraint Stress
Two weeks following the end of the metabolic assessments,
the activation of the hypothalamus-pituitary-adrenal (HPA)
axis was assessed in response to a psychophysical stressful
challenge. All subjects underwent an acute restraint stress
(30 min) and blood samples were collected by a tail nick at
different time points, i.e., soon before (0 min) and following
(30, 180 and 240 min) the exposure to stress, in order to
measure plasma levels of corticosterone (CORT). Exposure
to stress took place at 02:30 p.m., when the levels of free
CORT were far from the circadian peak (Kitchener et al.,
2004). Blood samples (100 ml, approximate volume) were
collected individually in potassium EDTA coated tubes (1.6 mg
EDTA/ml blood, Sarstedt, Germany). All samples were kept
on ice and later centrifuged at 3000 rpm for 15 min at
+48 C. Blood plasma was transferred to Eppendorf tubes
for CORT determination and stored at  20 C until further
analysis. CORT was measured using a commercially available
radioimmunoassay (RIA) kit containing 125iodine labeled CORT;
5 µl of plasma were sufficient to carry out CORT measurement.
Sensitivity of the assay was 0.125 µg/dl, inter- and intra-assay
variation was less than 10 and 5%, respectively (MP Biomedicals
Inc., CA, USA). Vials were counted for 2 min in a gamma
scintillation counter (Packard Minaxi Gamma Counter, Series
5000).
Measurement of Glutathione in
Hypothalamus (HYPO) and Brown Adipose
Tissue (BAT)
The amount of total glutathione equivalents (GSH +
GSSG) were measured in mouse hypothalamic and brown
adipose tissue homogenates by DTNB according to the
manufacturer instructions (Glutathione Assay Kit, Cayman
Chemicals, Ann Arbor, MI, USA). Briefly, hypothalamic
tissues were homogenized in phosphate buffer containing
1 mM EDTA. After centrifugation at 10,000⇥ g for 15 min
at 4 C, the supernatants were deproteinated by adding an
equal volume of metaphosphoric acid. The pH of samples
was set in a range of 6–7 by triethanolamine (Sigma-
Aldrich). Samples were diluted 1:2 with MES Buffer (0.2 M
2-(N-morpholino) ethanesulfonic acid/0.05 M phosphate/1 mM
EDTA) and then assayed for total glutathione quantification
by the addition of a mix containing: DTNB, glutathione
reductase, NADP+, glucose-6-phosphate and glucose-6-
phosphate dehydrogenase. The absorbance at 412 nm was
detected by the Appliskan Microplate Reader (Thermo
Scientific).
Emotional Phenotype
After 2 weeks of washout from the manipulation required to
assess plasma CORT levels, all subjects underwent an open field
(OF) followed (2 days later) by an elevated plus maze (EPM)
Test in order to assess spontaneous and emotional behavior
respectively (Pellow et al., 1985; File, 1993). All tests were
performed during the active (dark) phase of the cycle between
09:00 and 13:00.
Open Field (OF)
Each subject was individually placed in the center of a cubic arena
(OF box 40 ⇥ 40 ⇥ 40 cm) made of Plexiglas and allowed to
freely explore for a single session lasting 15 min. The OF box
was ideally divided into 25 squares and ideally partitioned into
a central portion (24 ⇥ 24 cm) and a peripheral one, identified
as the remaining part of the arena. When data were analyzed, the
session was subdivided in three time blocks (tb), lasting 5 min,
and the time spent in each portion of the arena was measured.
Furthermore, the frequency of sniffing and rearing was scored
as index of exploratory behavior and the latency and frequency
of immobility were considered as index of emotional profile.
Grooming frequency and the latency to the first event were also
taken into account, providing a reliable marker of high or low
stress in a specific behavioral context (Katz and Roth, 1979;
Kalueff and Tuohimaa, 2005).
Elevated Plus Maze (EPM)
The EPM is made of two open arms (30 ⇥ 5 ⇥ 0 cm) and two
closed arms (30 ⇥ 5 ⇥ 15 cm) that extended from a common
central platform (5 ⇥ 5 cm). The apparatus, made of Plexiglas
(gray floor, clear walls), is elevated to a height of 60 cm above
the floor. Mice were individually placed on the central platform
facing an open arm and allowed to freely explore the maze for
5 min. Behavioral parameters observed were: % open entries
[(open/total)⇥ 100] and time spent in the open and closed arms
of the maze (File, 2001). Furthermore, the behavioral parameters
taken into account were the frequency of head-dipping (HEAD)
and of explorative behavior such as sniffing and locomotion
(crossings of squares limits with all paws).
Illumination was provided by means of two tall floor lamps
with translucent shades placed at opposite corners of the room
providing an equal light intensity between the periphery and the
central part of the OF as well as between the open and closed
arms. The total luminosity was 400 lux on average. Behavioral
performances were video recorded and the behavioral analysis
was carried out from the video by an observer blind to the
prenatal treatment, using commercial software (The Observer
10XT, Noldus, Netherlands). At the end of each behavioral
session apparatuses were cleaned by a cotton pad wetted with a
50% solution of ethanol and water.
Statistical Analysis
Data were analyzed using parametric analysis of variance
(ANOVA) with Treatment (Maternal NAC vs. WATER), Diet
(Maternal HFD vs. CD) and Sex (females vs. males) as between-
subjects factors and time blocks as within-subjects repeated
measures, when appropriate (GTT, IST, CORT and OF tests).
‘‘Zones’’ were also considered as a within-subject factor for the
EPM (‘‘center’’ vs. ‘‘closed arms’’ vs. ‘‘open arms’’) and the OF
(‘‘center’’ vs. ‘‘periphery’’ as a within-subjects factor) to account
for the preference of subjects for the different areas of the
maze/arena.
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Post hoc comparisons were performed using the Tukey’s test.
In the case of GTT and IST Tukey’s post hoc comparisons were
performed also in the absence of significant ANOVA effects
(Diet ⇥ Treatment ⇥ Time course) according to the indications
given by Wilcox et al. (1987). When a main effect of sex was
found, separate analyses for females and males were performed.
A level of probability set at p < 0.05 was used as statistically
significant. Data are presented graphically as means + SEM.
Statistics were performed with Statview II (Abacus Concepts,
Berkeley, CA, USA).
RESULTS
Dams’ Body Weight
Overall, HFD feeding increased body weight in all dams (main
effect of diet: F(1,35) = 37.320; p < 0.0001). An interaction
among treatment, diet and time was found during the last
week of combined exposure to HFD and NAC (F(5,175) = 2.978;
p = 0.0132) with NAC-CD and NAC-HFD females showing
increased body weight (b.w.) when compared to their respective
controls (WATER-CD andWATER-HFD; post hoc comparisons
p< 0.01 and p< 0.05 respectively; see Figure 2A).
Body Weight of the Offspring and Body
Mass Index (BMI)
Overall NAC increased the b.w. of the offspring on PND 3 (main
effect of NAC: F(1,30) = 9.734, p = 0.004, Figure 2B) and on
PND 90 (F(1,64) = 65.011, p < 0.0001). By contrast, prenatal
exposure to maternal HFD increased offspring’s body weight
specifically on PND 30 (main effect of HFD: F(1,63) = 13.547,
p = 0.0005, Figure 2C) but not on PND 3 and PND 90 (main
effect of maternal diet: F(1,30)(1,64) = 0.104; 0.698, p = 0.7489;
0.4065, respectively on PND 3 and on PND 90). In addition,
on PND 30 and PND 90 an interaction between maternal
diet and NAC was found, with NAC contributing to increase
body weight in HFD offspring on PND 30 (F(1,63) = 5.828,
FIGURE 2 | Body weight of dams and offspring. (A) HFD increased dams’ body weight during both peri-conceptional time and pregnancy (gray shade) moreover,
NAC increased dams’ body weight on week 5. (B) Prenatal NAC increased pups’ body weight on PND 3; (C) on PND 30 HFD overall increased pups’ body weight
particularly when in combination with NAC (D) this effect was reverted on PND 90. Data are mean ± SEM (dams) and + SEM (pups); $p < 0.05, main effect of NAC;
£p < 0.05, main effect of HFD; ⇤⇤p < 0.01 NAC-CD vs. NAC-HFD (A); ⇤p < 0.05, NAC-HFD vs. WATER-HFD (A); NAC-HFD vs. NAC-CD (C); NAC-CD vs.
WATER-CD (D).
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p = 0.0187, Figure 2C), while having an opposite effect on PND
90 (F(1,64) = 25.363, p< 0.0001, Figure 2D).
As for BMI, while neither NAC or maternal HFD determined
differences among groups (main effect respectively of NAC and
maternal diet: F(1,55) = 2.421; 0.005, p = 0.1255; 0.9433), sex
strongly affected this parameter with males being characterized
by a higher BMI than females (main effect of sex: F(1,55) = 19.575,
p < 0.0001). In addition, an interaction among NAC, HFD and
sex (F(1,55) = 6.962, p = 0.0108) was found with NAC-HFDmales
showing a higher BMI than females of the same group (data not
shown).
Metabolic Regulation
Glucose Tolerance Test (GTT)
Overall, a main effect of sex was found (main effect of sex:
F(1,64) = 92.889, p < 0.0001) thus male and female subjects
were analyzed independently in order to better characterize
the metabolic response in the two sexes. Maternal HFD
did not affect glycaemia per se in males (main effect of
diet: F(1,33) = 0.059; p = 0.8096) or females (main effect of diet:
F(1,31) = 0.707, p = 0.4069), by contrast, prenatal exposure to
NAC improved glucose tolerance in males only (F(1,33) = 12.298;
p = 0.0013). Indeed, although the interaction among Diet,
Treatment and Time course failed to show statistical significance
(F(4,132) = 0.823; p = 0.5129), post hoc comparisons revealed
improved glucose tolerance at 30 and 60 min in NAC-CD
subjects (p < 0.001; Figure 3A). No interaction effects were
observed in females (F(4,124) = 1.139; p = 0.3414, Figure 3B).
Insulin Sensitivity Test (IST)
Since sex interacted significantly with Diet and Treatment
(Treatment ⇥ Diet ⇥ Sex: F(1,62) = 8.243, p = 0.0056) data
were analyzed independently in order to better characterize the
metabolic response in the two sexes. In male mice, NAC alone
resulted in improved insulin sensitivity, an opposite effect was
found when this was administered in combination with HFD
FIGURE 3 | Glucose tolerance test (GTT) and insulin sensitivity test (IST). Glucose tolerance: (A) NAC-CD males were characterized by improved glucose tolerance
particularly 30 and 60 min following glucose loading. (B) No difference was found among treatment groups in females. Insulin sensitivity: (C) Interestingly, NAC-CD
males showed improved insulin sensitivity 60 min following insulin injection. By contrast, the NAC-HFD subjects showed an overt worsening of the glycaemic profile.
(D) Females showed a glycaemic profile comparable to that of NAC-HFD comparable males as a result of NAC alone. Data are mean ± SEM; ⇤⇤p < 0.01: (A)
NAC-CD vs. all other treatment groups at time points 30 and 60. (C) NAC-HFD vs. all other treatment groups at time points 15 and 30; WATER-HFD and NAC-HFD
vs. WATER-CD and NAC-CD at time point 120; (D) NAC-CD vs. WATER-CD at 15 and 120 min. ⇤p < 0.05: (C), NAC-CD vs. all other treatment groups at time point
60; (D), NAC-CD and WATER-HFD vs. WATER-CD at time point 30; WATER-HFD vs. WATER-CD at time point 60.
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(F(1,33) = 6.291, p = 0.0172, post hoc NAC-HFD vs. NAC-CD
p< 0.01). This insulin resistance effect was observed at each time
point following insulin injection (interaction among maternal
diet, treatment and time, F(4,132) = 3.087, p = 0.0182; Figure 3C).
In females, prenatal NAC overall resulted in decreased insulin
sensitivity, regardless of prenatal diet (main effect of NAC:
F(1,30) = 8.604, p = 0.0064, Figure 3D). Post hoc comparisons
performed on the interaction among treatment, diet and time
(F(4,120) = 1.598; p = 0.1792) revealed that this effect was apparent
at 15 (NAC-CD vs. WATER-CD and NAC-HFD vs. WATER-
HFD, p< 0.01) and 30min (NAC-CD vs.WATER-CD, p< 0.05)
following insulin injection. Moreover, when compared to the
control condition (WATER-CD) treatment with HFD led to
a worsening of the glycaemic profile at 30 (p < 0.05) and at
120 min (p < 0.01; WATER- HFD vs. WATER- CD p < 0.05).
These post hoc comparisons were performed in the absence of a
significant ANOVA effects (Diet ⇥ Treatment ⇥ Time course)
according to the indications given by Wilcox (Wilcox et al.,
1987).
Adiponectin Levels
Overall, prenatal treatment with NAC increased circulating
adiponectin levels (main effect of treatment: F(1,33) = 5.065;
p = 0.0312) while neither diet or sex affected adiponectin levels
per se (F(1,33) = 0.002; 0.108; p = 0.9671; 0.7440, respectively
for diet and sex). By contrast, a significant interaction between
treatment and sex showed that NAC increased this adipokine in
males but not in females (F(1,33) = 6.366; p = 0.0166; post hoc:
males-NAC vs. males-WATER p< 0.01, Figures 4A,B).
Leptin Levels
Overall, prenatal treatment with NAC decreased circulating
leptin levels (main effect of treatment: F(1,45)= 18.316;
p < 0.0001). Moreover, NAC not only decreased leptin
levels in males but was particularly effective in preventing
the HFD-driven increase in leptin levels in female offspring
(interaction among treatment, diet and sex: F(1,45) = 6.393;
p = 0.0150, post hoc: water-HFD-females vs. NAC-HFD-females,
p< 0.01, see Figures 4C,D).
Plasma Corticosterone in Response to
Restraint Stress
As a main effect of sex was found (F(1,55) = 9.335, p = 0.0035), a
further analysis was ran separately for males and females.
In males, NAC led to overall reduced CORT response to
restraint stress (main effect of NAC: F(1,29) = 36.729; p< 0.0001).
This decrease was stronger in NAC-CD subjects, maternal HFD
reducing this effect (F(3,87) = 6.344, p = 0.0006, post hoc p< 0.001,
Figure 5A).
As for females, no main effects of treatment (F(1,26) = 0.182;
p = 0.6728) or diet (F(1,26) = 0.096, p = 0.7590) were found.
In females, the combination of prenatal NAC and HFD led to
a reduction in CORT levels comparable to that observed in
NAC-HFD males (F(1,26) = 8.867, p = 0.0062, post hoc p < 0.05,
Figure 5B).
FIGURE 4 | Adiponectin and Leptin plasma levels. (A) NAC increased
adiponectin in males while (B) no effect was observed in females. (C) An
opposite effect of NAC was observed for leptin levels in males. (D) In females,
this reduction of leptin levels was much stronger since they were more
vulnerable to the effects of HFD. Data are mean + SEM. Main effect of NAC:
$$p < 0.01 (A,C,D); ⇤⇤p < 0.01 (D), NAC-HFD vs. WATER-HFD (females).
Glutathione Levels in Hypothalamus and
Brown Adipose Tissue (BAT)
As for the hypothalamus, a main effect of sex showed that
females were characterized by reduced levels of glutathione
in this brain area (F(1,24) = 215.817; p < 0.0001). NAC led
to an increase in the levels of total glutathione in males
but not in females (main effect of NAC: F(1,24) = 16.807;
p = 0.0004). Furthermore, an interaction among sex, treatment
and diet was found with male WATER-HFD subjects showing
reduced glutathione levels when compared to the control group
(F(1,24) = 5.526; p = 0.0273; post hoc: WATER-HFD vs. WATER-
CD, p< 0.01; see Figures 6A,B).
As for Brown Adipose Tissue (BAT), a main effect of sex
showed that females were characterized by increased glutathione
levels in this fat depot (F(1,16) = 5.485; p = 0.0324. NAC led to
an increase in the levels of total glutathione both in males and in
females (main effect of NAC: F(1,16) = 27.310; p< 0.0001). In this
regard, it is interesting to note that the profile of total glutathione
observed in males in this fat compartment, was very similar to
that observed in the hypothalamus. In addition, an interaction
among sex, treatment and diet was found (F(1,16) = 4.460;
p = 0.0508) showing higher glutathione levels in the NAC-CD
females when compared to their controls (post hoc: NAC-CD
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vs. WATER-CD, p < 0.01), such effect was reduced in the
NAC-HFD group (post hoc: NAC-CD vs. NAC-HFD, p < 0.05;
see Figures 6C,D).
Emotional Phenotype
Open Field (OF)
All mice spent more time in the periphery of the arena
(main effect of zone: F(1,52) = 2293.444, p < 0.0001). By
contrast, prenatal NAC administration increased the time spent
in the center of the OF (interaction between treatment and
zone: F(1,52) = 59.384, p < 0.0001) as well as the locomotor
activity (interaction between zone and treatment for crossing
frequency: F(1,52) = 23.574, p < 0.0001); see Figure 7A.
Overall, NAC-treated mice appeared to be more explorative.
Indeed, they showed an increased latency to first immobility
bout as well as a reduced frequency and duration of this
behavior (main effect of treatment: F(1,52) = 63.096, 46.871,
40.927; p < 0.0001 respectively for latency, frequency and
duration, Figure 7B). Moreover, all NAC-treated subjects
were characterized by increased rearing frequency, particularly
NAC-CD mice (interaction between diet and treatment:
F(1,52) = 5.296; p = 0.0254) and by a reduced duration of this
behavior (main effect of treatment (F(1,52) = 138.022; p< 0.0001,
Figure 7B). No effects were observed on rearing latency (main
effect of treatment: F(1,52) = 1.262; p = 0.2664). Treatment with
NAC affected also SAP behavior. In fact, all mice showed a reduce
latency and increased frequency and duration of this behavior
(main effect of treatment: F(1,52) = 21.134, 132.342, 143.809;
p < 0.0001, respectively for latency, frequency and duration;
see Figure 7B). As for SAP duration, the effect was particularly
apparent in the NAC-HFD group (F(1,52) = 10.322; p = 0.023,
post hoc: WATER-HFD vs. NAC-HFD p < 0.01; Figure 7B).
Moreover, prenatal NAC treatment resulted in increased
grooming frequency (main effect of treatment: F(1,52) = 50.174;
p< 0.0001) but no effect was observed on latency (F(1,52) = 0.621,
0.374 and duration (F(1,52) = 0.374; p = 0.5436).
Elevated Plus Maze (EPM)
Overall, all subjects spent more time in the closed arms of the
apparatus (main effect of zone: F(2,106) = 27.553, p < 0.0001).
An interaction between zone an treatment showed that, when
compared to controls, NAC-treated mice spent more time in the
open arms of the maze (F(2,106) = 5.499; p = 0.0053; Figure 8A).
Regardless of both maternal diet and sex, NAC mice showed an
increased locomotion when compared to controls (main effect
of NAC on frequency of crossing: F(1,53) = 5.666, p = 0.0209, see
Figure 8B), as well an increased frequency of SAP, which was also
found in the HFD offspring (main effects of NAC and maternal
diet respectively: F(1,53) = 5.620; 4.357, p = 0.0214; 0.0417).
While NAC, maternal diet and sex did not affect the
latency to the first episode of HEAD (main effects of NAC,
maternal diet and sex respectively: F(1,53) = 2.009; 0.289; 0.129,
p = 0.1623; 0.5931; 0.7209), an interaction among them was
found, with NAC-CD females showing a longer latency than
males (F(1,53) = 4.428, p = 0.0401). Moreover, NAC mice
performed HEAD with a reduced frequency than controls (main
effect of NAC: F(1,53) = 14.404, p = 0.0004). The NAC group
also showed increased latency to the first episode of grooming
behavior not affecting its frequency and duration (main effect
of NAC: F(1,53) = 4.824; 0.135; 1.345, p = 0.0325; 0.7152; 0.2514,
respectively for latency, frequency and duration).
DISCUSSION
Overall, results from this study show that prenatal NAC
administration counteracts some of the short- and long-term
negative effects observed following in utero exposure to HFD.
As an example, in females, NAC administration was able to
FIGURE 5 | Activation of the hypothalamus-pituitary-adrenal (HPA) axis after restraint stress. (A) In males, NAC led to overall decreased corticosterone (CORT) levels.
This decrease was stronger in NAC-CD subjects, maternal HFD reducing this effect. (B) In females, the combination of prenatal NAC and HFD led to a reduction in
CORT levels comparable to that observed in NAC-HFD males while NAC alone did not affect this parameter. Data are mean ± SEM. ⇤⇤⇤p < 0.001 (A) NAC-CD vs. all
other groups and NAC-HFD vs. all other groups; ⇤p < 0.05 (B) 30 min, NAC-HFD vs. all other groups.
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FIGURE 6 | Levels of glutathione in peripheral and central tissues. Hypothalamus: (A) glutathione levels were lowered by diet in male subjects (WATER-HFD).
Independently from prenatal HFD, all males showed higher glutathione levels as a result of NAC administration. (B) Females mice showed reduced glutathione levels
in this area and appeared to be more resilient to changes either upon HFD or NAC. Brown Adipose Tissue (BAT): (C) Both male and female subjects showed an
increase in glutathione levels upon NAC administration. (D) In addition, females show a significant increase in glutathione (NAC-CD) that was reduced upon HFD
administration (NAC-HFD). Data are mean + SEM. ⇤⇤p < 0.01 for WATER-HFD vs. WATER-CD in male (A) and NAC-CD vs. WATER-CD (D); ⇤p < 0.05 for NAC-HFD
vs. NAC-CD (D). $$p < 0.01 main effect of NAC (A,C,D).
reduce high levels of leptin resulting from prenatal HFD. Prenatal
NAC administration also resulted in greater glucose tolerance
and insulin sensitivity while increasing adiponectin levels, as well
as increasing exploratory behavior, an effect accompanied by
a reduced plasma corticosterone levels in response to restraint
stress. Analysis of glutathione—an endogenous substance with
antioxidant properties—in the hypothalamus and in brown
adipose tissue indicates that, while HFD administration to
pregnant dams led to lower levels of glutathione in the male
hypothalamus, NAC was able to revert this effect both in the
periphery (BAT, bothmales and females) and in the CNS (males).
This explains some of the positive long-term and sex-dependent
effects of NAC administration per se. These data are in line with
previous results from our group suggesting that the oxidative
milieu during pregnancy can have important health outcomes
on the offspring (Berry and Cirulli, 2013; Bellisario et al.,
2014).
Exposure to HFD feeding during pregnancy represents a
metabolic stressful challenge negatively affecting physiological
adaptation to pregnancy. In this study maternal HFD led to an
overall increase in body weight in all dams that was apparent
in the offspring on PND 30, an effect possibly potentiated by
weaning as previously shown with an equivalent animal model
(Bellisario et al., 2014). NAC administration alone resulted
in increased birth weight of the offspring on PND 3 and at
adulthood PND 90.
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FIGURE 7 | Spontaneous behavior in the OF test. In general, NAC led to a reduced emotionality and increased exploration in the OF test (A). NAC-treated subject
spent more time and were characterized by increased locomotion in the central part of the arena when compared to controls. In the plus-maze test, NAC mice
showed an increased latency and a reduced frequency and duration of immobility (B). NAC increased rearing bouts, particularly in CD subjects while decreasing the
overall duration of this behavior (B). In addition, the latency to the first risk-assessment episode (stretched-attend posture—SAP) was strongly reduced in
NAC-treated mice while the frequency was increased; the combination of prenatal NAC and HFD increased the duration of the stretched-attend-posture behavior
(B). Data are mean + SEM $$p < 0.01, NAC vs. WATER; ⇤⇤p < 0.01; NAC-CD vs. NAC-HFD.
When circulating adipokines were measured, prenatal HFD
resulted in increased leptin levels in females, a phenomenon
we have previously described (Bellisario et al., 2014). Here
we show that this effect can be prevented by maternal
NAC administration. In addition, NAC led to an overall
increase in adiponectin levels, particularly in males. Leptin and
adiponectin are two major adipokines involved in the control
of metabolic homeostasis. Leptin affects food consumption
and energy expenditure (Friedman and Halaas, 1998) acting
directly on the hypothalamus (a brain region involved in energy
homeostasis) and hyperleptinemia has been associated to obesity
and the related disorders (Considine et al., 1996). By contrast,
adiponectin increases tissue fat oxidation, leading to reduced
levels of fatty acids and tissue triglyceride content, overall
increasing insulin sensitivity (Matsuzawa et al., 2004). Thus, at
least as far as adipokines are concerned, we can hypothesize an
increased developmental flexibility of females offspring resulting
both in an elevated vulnerability to a suboptimal metabolic
intrauterine environment as well as in a more efficient response
to NAC treatment, while males might be characterized by a
higher metabolic resilience.
The interpretation of metabolic assessments at adulthood is
more complex. In particular, HFD did not affect, per se, glucose
tolerance or insulin sensitivity.While inmales NAC alone (NAC-
CD group) led to a more effective glycemic profile, as assessed
both in the GTT and IST, this was not observed in females. In the
case of insulin sensitivity, it appears that subjects experiencing
prenatal NAC in combination with HFD were characterized by
decreased insulin sensitivity. A potential explanation for this
result comes from the consideration that, although the excessive
production of ROS is associated with many human diseases, in
recent years it has become apparent that low levels of H2O2
may in fact be required for normal cellular functioning and
intracellular signaling (Veal et al., 2007; see also further in the
‘‘Discussion’’ section).
Assessment of HPA axis reactivity showed that, while
HFD did not affect, per se, the neuroendocrine response to
a psychophysical stress (restraint), NAC, alone (males) or in
combination with HFD (females), overall led to a blunted rise
in CORT levels in response to stress. Glucocorticoid hormones
(GC) show a very broad variety of actions inducing alert
responses through the activation of metabolic and behavioral
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FIGURE 8 | Emotional behavior in the EPM test. All subjects spent more time in the closed arms of the maze although a significant interaction between zone and
prenatal treatment revealed that NAC mice spent significantly more time in the open arms when compared to their controls (A) In addition, all NAC subjects were
characterized by increased locomotion (n. of crossings, B). Data are mean + SEM. ⇤p < 0.05, open arms: NAC vs. WATER; $$p < 0.01, NAC vs. WATER.
processes (Oitzl et al., 1997). Interestingly, NAC treated
subjects were overall characterized by a decreased emotionality
as—differently from HFD-mice—they spent more time in the
center of the arena, were less immobile and more explorative
in the OF test, in agreement with the reduced activation of
the HPA axis. In addition, they showed reduced emotionality
in the Elevated Plus-Maze test spending more time in the
open (anxiogenic) arms of the maze. Previous authors have
found a link between genes involved in the regulation of OS
and emotionality suggesting a tight relationship between OS
metabolic pathways and normal anxiety (Hovatta et al., 2005).
When compared with previous data obtained in other animal
model, such as the p66Shc /  mouse (Berry et al., 2007, 2008;
Berry and Cirulli, 2013) these results strengthen the notion of a
link among OS, metabolism and emotional behavior, indicating
a potential role for antioxidants in the management of anxiety
and/or psychiatric disorders (Giorgio et al., 2012; Berry and
Cirulli, 2013).
Overall, in this study, while prenatal HFD did not show
pervasive effects on the metabolic or emotional profile of the
experimental subjects, NAC-treated mice showed improved
glucose tolerance in addition to a reduced activation of the HPA
axis upon restraint stress. Moreover, when tested in the OF
and in the Elevated Plus-Maze, they were characterized by a
reduced emotional profile. Intriguingly, the observed effects of
prenatal NACmirror the overall phenotype of p66Shc knock-out
mice previously described (Berry and Cirulli, 2013; Bellisario
et al., 2014). Since this is an animal model of reduced OS and
healthy aging, these data might suggest that the prenatal-NAC-
phenotypic features might be protective upon further metabolic
or stressful challenges that could be experienced at adult age.
This hypothesis is strengthened by data showing meaningful
effects of NAC on glutathione levels, a powerful antioxidant
and a ROS scavenger, in central (hypothalamus) and peripheral
(brown fat) tissues. Data indicate that, while HFD administration
to pregnant dams leads to reduced levels of glutathione in male
hypothalamus, NAC is able to revert this effect and to increase
levels of glutathione in the periphery (BAT, both males and
females). Females appear overall more resistant to changes in
glutathione levels in the CNS compared to males, while the
opposite holds true in the periphery.
Tight regulation of the redox balance, particularly in a
developing organism is crucial for the maintenance of proper
cell function (Ristow et al., 2009). Although antioxidant therapy
is currently emerging as a promising strategy to counteract the
prevalence of diabetes and other metabolism-related pathologies,
in addition to anxiety and psychiatric disorders, unfortunately,
major randomized clinical trials have yielded conflicting results
(Falach-Malik et al., 2016). Results from this study, performed
in an animal model, indicate positive effects of NAC given
during pregnancy on the developing offspring although they
also raise some questions concerning safety. A wide variety of
stimuli including growth factors and hormones can promote
the transient generation of H2O2, and recent data provide clear
evidence for the enhancement of insulin signaling by ROS
in vivo (Loh et al., 2009). This might suggest that lowering
excessively ROSmight endanger signal transductionmechanisms
they regulate.
Overall, these data indicate that a major challenge for
future investigations will be to determine the optimal dose of
compounds capable to keep the redox balance within an optimal
range, taking into account physiological functions involving
redox-sensitive pathways, age- and sex/gender differences.
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